Long-term effects of finasteride on prostate tissue composition - results of a four-year placebo-controlled trial (abstract)

Author： Marks L.S.   Partin A.W.   Dorey F.J.   Gormley G.J.   Epstein J.I.   Garris J.B.   Macairan M.L.   Shery E.D.   Santos P.B.   Stoner E.   deKernion J.B.  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.53, Iss.3, 1999-03, pp. : 574-580

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo

By Roehrborn C.G.   Boyle P.   Bergner D.   Gray T.   Gittelman M.   Shown T.   Melman A.   Bracken R.B.   deVere White R.   Taylor A.   Wang D.   Waldstreicher J.   for the PLESS Study Group  

Urology, Vol. 54, Iss. 4, 1999-10 ,pp. : 662-669

Elsevier

Access to resources Recommend Favorite

Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy? - results of a randomized, double-blind, placebo-controlled clinical trial

By Yang X.J.   Lecksell K.   Short K.   Gottesman J.   Peterson L.   Bannow J.   Schellhammer P.F.   Fitch W.P.   Hodge G.B.   Parra R.   Rouse S.   Waldstreicher J.   Epstein J.I.  

Urology, Vol. 53, Iss. 4, 1999-04 ,pp. : 696-700

Elsevier

Access to resources Recommend Favorite

Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial - results of the VA Cooperative Study #359 (abstract)

By Andriole G.L.   Guess H.A.   Epstein J.I.   Wise H.   Kadmon D.   Crawford E.D.   Hudson P.   Jackson C.L.   Romas N.A.   Patterson L.   Cook T.J.   Waldstreicher J.  

Urology, Vol. 52, Iss. 2, 1998-08 ,pp. : 195-202

Elsevier

Access to resources Recommend Favorite

Long-Term Evaluation of Tamsulosin in Benign Prostatic Hyperplasia: Placebo-Controlled, Double-Blind Extension of Phase III Trial - risk factors and concomitance with hypertension

By Lepor H.  

Urology, Vol. 51, Iss. 6, 1998-06 ,pp. : 901-906

Elsevier

Access to resources Recommend Favorite

Can finasteride reverse the progress of benign prostatic hyperplasia? a two-year placebo-controlled study

By Andersen J.T.   Ekman P.   Wolf H.   Beisland H.O.   Johansson J.E.   Kontturi M.   Lehtonen T.   Tveter K.  

Urology, Vol. 46, Iss. 5, 1995-11 ,pp. : 631-637

Elsevier

Access to resources Recommend Favorite